Febrifugine (1a) is an antimalarial agent which was isolated from Dichroa febrifuga or Hydrangea umbellata with isofebrifugine (1b).
Febrifugine (1a) is an antimalarial agent which was isolated from Dichroa febrifuga or Hydrangea umbellata with isofebrifugine (1b). 1) Recently Kobayashi et al. corrected the error in the absolute structures of 1a,b, as shown in Fig. 1 , by achieving the asymmetric syntheses of all the stereoisomers. 2) We have developed a new synthetic method for 1a,b, 3) and our interest next focused on the structure-activity relationship (SAR) of 1a,b. The difficulty in the purification or antimalarial screening of 1a,b is isomerization 4) between 1a and 1b, which occurs via a reversible Michael reaction. We thought that a derivative in which isomerization did not occur might be a more potent compound. Although much is reported on the SAR of substituents 5) on the 4(3H)-quinazolinone ring, the only known modification of the piperidine ring involves regioisomers of the hydroxy group. 6) In this report, we describe the synthesis and antimalarial activity of derivatives (2a,b) that are regioisomers of the nitrogen atom on the piperidine ring of 1a,b.
We prepared 2a,b from 1-benzyl-3-hydroxypyridinium chloride (3) in seven isolated steps by modifying our method for synthesizing 1a,b (Chart 1). The successive O-allylation, reduction, 7) and replacement 8) of the benzyloxycarbonyl (Cbz) group from 3 afforded benzyl 1-(3-allyloxy-1,2,5,6-tetrahydropyridine)carboxylate (4) in 47% yield. The Claisen rearrangement of 4 by heating at 140°C in xylene proceeded smoothly to give benzyl 4-allyl-3-oxo-1-piperidinecarboxylate (5) in 99% yield. Reduction of 5 with sodium borohydride (NaBH 4 ) afforded trans (6a) and cis (6b) benzyl 4-allyl-3-hydroxy-1-piperidinecarboxylate as an inseparable mixture.
Purification and structural determination of the inseparable mixture of 6a and 6b were achieved as shown in Chart 2. Although trans (12a) and cis (12b) benzoate produced from 6a,b were separated by column chromatography, the existence of rotomers 9) in the 1 H-NMR spectrum made the structural analysis of 12a,b difficult. Hydrogenolysis of 12a,b produced trans (13a) or cis (13b) 4-propyl-3-piperidinyl benzoate, respectively. In the 1 H-NMR spectrum, the proton at the 3 position on the piperidine ring of 13a was observed at 4.73 ppm with a coupling constant of 4.0 and 9.5 Hz. The proton on 13b, on the other hand, was observed at 5.10 ppm as a single broad peak. Pure 6a and 6b were prepared by hydrolysis of 12a and 12b and led to 7a and 7b, respectively.
We previously found that reduction of benzyl 2-allyl-3-oxo-1-piperidinecarboxylate (14) with NaBH 4 at room tem-perature gave cis-benzyl 2-allyl-3-hydroxy-1-piperidinecarboxylate (15b) in high yield as the sole product, without involving the diastereomeric isomer. 3a,b) As an additional experiment, we attempted reduction of 14 with super hydride
Bu 3 H) ( Table 1 ). The high cis selectivity in the reduction was maintained, although it decreased in the order NaBH 4 , LiBEt 3 H, LiB iϪ Bu 3 H. In contrast, reduction of the 4-allyl derivative (5) with NaBH 4 afforded trans selectivity to generate a mixture of 6a and 6b.
We predicted cis selectivity in the reduction of 14 with hydride from a conformational analysis of 14 using molecular calculations. 3a,b) In order to confirm our prediction, we calculated 10) the stable conformers of 16 and 17, which were selected as convenient models of 5 and 14 (Fig. 2) . The difference in the heat of formation (H.F.) between the minimized conformer (16b) having the allyl group at the axial position and the optimized conformer (16a) having the allyl group at the equatorial position was about 3.0 kcal/mol; between 17b and 17a it was Ϫ0.6 kcal/mol. Considering the generation of cis alcohol from 16b or 17b, our prediction is consistent with experimental determinations of selectivity.
The reaction of a mixture of 6a,b with N-bromosuccinimide (NBS) gave a mixture of separable intramolecular bromoetherified products (7a,b). The HPLC data for 7a indicated that this was a 3.6 : 1 mixture of the diastereomeric isomers. The methoxy compound (8a) could be prepared in high yield (83%) as a 1 : 2 mixture of the diastereomeric isomers by dehydrobromination using potassium tert-butoxide and bromoetherification using NBS and methanol. Deacetalization of 8a followed by a coupling reaction with 4(3H)-quinazolinone (9) afforded 10a in 81% yield. The hydrogenolysis of 10a gave 2a in 37% yield as a crystalline solid. To increase the yield of hydrogenolysis, we treated 10a with acid in an unsuccessful attempt to give the N-benzylated compound (11a) of 2a along with 2a. Similarly, the diastereomer (2b) of 2a was synthesized from 7b. Contrary to our expectations, the 13 C-NMR spectrum made it clear that 2b was present in the keto form, not the hemi-acetal form (2b in Chart 1).
The in vitro antimalarial activities of compounds 1a,b, 2a,b, 10a,b, and 11a against Plasmodium falciparum were 
Experimental
Melting points were determined on a Yanagimoto micro melting point apparatus and are uncorrected. IR spectra were recorded on a JASCO A-102 spectrometer. Mass spectra (MS) were recorded on a VG-70SE spectrometer.
1 H-and 13 C-NMR spectra were run on a JASCO MY 60FT or a Varian VXR-500 spectrometer. Analytical HPLC was performed with a Shimadzu SPD-6A instrument on a silica gel column, Chemcosorb 5Si-U (Chemco). Merck Silica gel 60 (230-400 mesh) and Wako activated alumina (300 mesh) were employed for column chromatography.
Benzyl 1-(3-Allyloxy-1,2,5,6-tetrahydropyridine)carboxylate (4) NaH (4.40 g, 0.11 mol as 60% dispersion in mineral oil) was added portionwise to an absolute MeOH (50 ml). To the solution, 1-benzyl-3-hydroxypyridinium chloride (22.17 g, 0.10 mol) and allyl bromide (9.6 ml, 0.11 mol) were added. After reflux for 4 h, the mixture was cooled and NaBH 4 (3.78 g, 0.10 mol) was added portionwise at 0°C. The mixture was stirred at 0°C for 0.5 h, then was acidified with aqueous 10% HCl solution and basified with aqueous saturated KHCO 3 solution. The mixture was poured into water and extracted with AcOEt. The combined organic layers were washed with brine, dried, and then the solvent was removed. Benzyl chloroformate (28.5 ml, 0.20 mol) was added dropwise to a solution of the residue in dry tetrahydrofuran (THF) (50 ml) at 0°C. The mixture was stirred at room temperature for 2.5 h and the solvent was removed. The residue was purified by column chromatography (SiO 2 , AcOEt : hexaneϭ1 : 15) to give 4 (12.83 g, 47%) as colorless needles. This compound was identified by spectral comparison with authentic samples obtained by our previous method. Reduction of 5 with NaBH 4 NaBH 4 (0.51 g, 13.5 mmol) was added portionwise to a solution of 5 (7.39 g, 27.0 mmol) in abs. MeOH (50 ml) at 0°C. The mixture was stirred at the same temperature for 15 min and poured into aqueous 10% HCl solution, then was extracted with AcOEt. The AcOEt layer was washed with aqueous saturated KHCO 3 solution and brine, dried, and solvent was removed to give an almost pure mixture of trans (6a) and cis (6b) benzyl 4-allyl-3-hydroxy-1-piperidinecarboxylate (7.25 g, 97%) as colorless oil. HPLC conditions: column, Chemcosorb 5Si-U; temperature, room temperature; solvent, AcOEt : hexaneϭ1 : 5; flow rate, 1.0 ml/min; wavelength, 254 nm; retention time, t R ϭ16.2 and 18.7 min (31 : 63). IR (neat) cm 3.0 mmol) was added dropwise to a solution of 5 (0.818 g, 3.0 mmol) in dry THF (5 ml) at 0°C. The mixture was stirred at the same temperature for 1 h and quenching of the reaction was performed by the methods described above to give an almost pure mixture of 6a and 6b (0.694 g, 84%) as colorless oil.
Reduction of 5 with LiB i؊
Bu 3 H LiB iϪ Bu 3 H (1.0 M solution in THF, 1.0 ml, 1.0 mmol) was added dropwise to a solution of 5 (0.274 g, 1.0 mmol) in dry THF (1 ml) at 0°C. The mixture was stirred at the same temperature for 4 h and quenching of the reaction was performed by the method described above to give an almost pure mixture of 6a and 6b (0.080 g, 29%) as colorless oil.
Reduction of 14 with NaBH 4 NaBH 4 (0.07 g, 1.85 mmol) was added portionwise to a solution of 14 3a,b) (1.00 g, 3.66 mmol) in MeOH (10 ml) at 0°C. The mixture was stirred at the same temperature for 1 h and poured into aqueous 10% HCl solution, then extracted with AcOEt. The AcOEt layer was washed with aqueous saturated KHCO 3 solution and brine, dried, and solvent was removed to give an almost pure mixture of trans (15a) and cis (15b) benzyl 2-allyl-3-hydroxy-1-piperidinecarboxylate (1.00 g, 100%) as colorless oil. HPLC conditions: column, Chiralcel OJ; temperature, room temperature; solvent, isopropyl alcohol : hexaneϭ3 : 37; flow rate, 1.0 ml/ min; wavelength, 254 nm; retention time, t R ϭ5.6, 6.2, and 8.1 min (1 : 499). The compounds were identified by spectral comparison with authentic samples obtained by our previous method.
Reduction of 14 with LiBEt 3 H LiBEt 3 H (1.0 M solution in THF, 7.32 ml, 7.32 mmol) was added dropwise to a solution of 14 3a,b) (1.00 g, 3.66 mmol) in dry THF (5 ml) at 0°C. The mixture was stirred at the same temperature for 2 h and quenching of the reaction was performed by the method described above to give an almost pure mixture of 15a and 15b (0.88 g, 87%) as colorless oil.
Reduction of 14 with LiB i؊
Bu 3 H LiB iϪ Bu 3 H (1.0 M solution in THF, 10.98 ml, 10.98 mmol) was added dropwise to a solution of 14 (1.00 g, 3.66 mmol) in dry THF (5 ml) at 0°C. The mixture was stirred at the same temperature for 2 h and quenching of the reaction was performed by the method described above to give an almost pure mixture of 15a and 15b (0.79 g, 79%) as colorless oil.
trans-(12a) and cis-(12b) Benzyl 4-Allyl-3-benzoyloxy-1-piperidinecarboxylate Benzoyl chloride (1.95 ml, 16.8 mmol) was added dropwise at 0°C to a mixture of 6a and 6b (4.13 g, 15.0 mmol), 4-(dimethylamino)pyridine (DMAP) (1.84 g, 15.1 mmol), and Et 3 N (2.3 ml, 16.5 mmol) in CH 2 Cl 2 (25 ml). The mixture was stirred at room temperature for 2.5 h and poured into aqueous 10% HCl solution, extracted with AcOEt. The AcOEt layer was washed with aqueous saturated KHCO 3 solution and brine, dried, and solvent was removed. The residue was purified by column chromatography (SiO 2 , AcOEt : hexaneϭ1 : 15) to give trans (12a, 61%) and cis (12b, 34%).
12a: Colorless oil. IR (neat) cm
Ϫ1
: 1720, 1700, 1270. 2,3,3a,4,7,7a-hexahydrofuro[2,3 -c]pyridine-6(5H)-carboxylate from a Mixture of 6a and 6b At 0°C, NBS (1.96 g, 11.0 mmol) was added to the solution of a mixture of 6a and 6b (2.75 g, 10.0 mmol) in MeCN (20 ml). The mixture was stirred at room temperature for 2 h and poured into aqueous 10% Na 2 S 2 O 3 solution, then extracted with AcOEt. The AcOEt layer was washed with saturated KHCO 3 solution and brine, dried, and the solvent was removed. The residue was purified by column chromatography (Al 2 O 3 , AcOEt : hexaneϭ1 : 9) to give 7a (2.13 g, 60%) and 7b (0.96 g, 27%).
(3aR*,7aR*)-Benzyl 2-(Bromomethyl)-2-methoxy-2,3,3a,4,7,7a-hexahydrofuro[2,3-c]pyridine-6(5H)-carboxylate (8a) Potassium tert-butoxide (3.00 g, 26.7 mmol) was added at 0°C to a solution of 7a (4.72 g, 13.3 mmol) in THF (15 ml) and the mixture was stirred at the same temperature for 1 h. Methanol (25 ml) and NBS (2.84 g, 16.0 mmol) were added and the mixture was stirred at room temperature for 1.5 h, then poured into aqueous 10% Na 2 S 2 O 3 solution and extracted with AcOEt. The AcOEt layer was washed with aqueous saturated KHCO 3 solution and brine, dried, and solvent was removed. The residue was purified by column chromatography (SiO 2 , AcOEt : hexaneϭ1 : 9) to give 8a (4.23 g, 83%) 2-methoxy-2,3,3a,4,7,7a-hexahydrofuro[2,3 -c]pyridine-6(5H)-carboxylate (8b) Potassium tert-butoxide (1.46 g, 13.0 mmol) was added at 0°C to a solution of 7b (2.30 g, 6.50 mmol) in THF (7 ml) and the mixture was stirred at the same temperature for 1 h. Methanol (15 ml) and NBS (1.39 g, 7.80 mmol) were added and the mixture was stirred at room temperature for 2 h. It was then poured into aqueous 10% Na 2 S 2 O 3 solution and extracted with AcOEt. The AcOEt layer was washed with aqueous saturated KHCO 3 solution and brine, dried, and solvent was removed. The residue was purified by column chromatography (SiO 2 , AcOEt : hexaneϭ1 : 9) to give 8b (2.14 g, 86%) as colorless oil. HPLC conditions: column, Chemcosorb 5Si-U; temperature, room temperature; solvent, AcOEt : hexaneϭ1 : 4; flow rateϭ1.0 ml/min; wavelength, 254 nm; t R ϭ8.9 and 10.1 min (17 : 66). IR (neat) cm
: 1700, 1220. Hydroxy-4-[2-oxo-3-(4-oxo-3(4H )-quinazolinyl) propyl]-1-piperidinecarboxylate (10a) Aqueous 10% HCl solution (6 ml) was added to a solution of 8a (2.89 g, 7.5 mmol) in MeCN (18 ml) and the mixture was stirred at room temperature for 0.5 h, then poured into water and extracted with AcOEt. The AcOEt layer was washed with aqueous saturated KHCO 3 solution and brine, dried, and solvent was removed. Quinazolinone (9, 1.09 g, 7.5 mmol) and anhydrous K 2 CO 3 (2.07 g, 15.0 mmol) were added to the solution of the residue in N, N-dimethylformamide (DMF) (10 ml) and the mixture was stirred at room temperature for 1 h, poured into water and extracted with AcOEt. The AcOEt layer was washed with brine, dried, and then solvent was removed. The residue was recrystallized from AcOEt to give 10a (2.67 (3R*,4S*)-Benzyl 3-Hydroxy-4-[2-oxo-3-(4-oxo-3(4H )-quinazolinyl)-propyl]-1-piperidinecarboxylate (10b) Aqueous 10% HCl solution (7 ml) was added to a solution of 8b (2.14 g, 5.57 mmol) in MeCN (15 ml) and the mixture was stirred at room temperature for 0.25 h, poured into water and extracted with AcOEt. The AcOEt layer was washed with aqueous saturated KHCO 3 solution and brine, dried, and then solvent was removed. Quinazolinone (9, 0.814 g, 5.57 mmol) and anhydrous K 2 CO 3 (1.54 g, 11.1 mmol) were added to the solution of the residue in DMF (10 ml) and the mixture was stirred at room temperature for 3.5 h, then was poured into water and extracted with AcOEt. The AcOEt layer was washed with brine, dried, and solvent was removed. The residue was recrystallized from CH 2 
cis-3-[3-(3-Hydroxy-4-piperidinyl)-2-oxopropyl]-4(3H)-quinazolinone (2b)
A mixture of 10b (0.103 g, 0.24 mmol) and 10% Pd/C (28.7 mg) in MeOH (3 ml) and CH 2 Cl 2 (5 ml) was stirred at room temperature for 32 h under a balloon of H 2 gas. The mixture was filtered and the solvent was removed. The residue was recrystallized from EtOH to give 2b (0.528 g, 82%) colorless needles, mp 233-235°C (dec. Antimalarial Activity Assays and evaluation of siderophore activities were carried out according to the methods described previously. 11) 
